TOP TIERMARKET NEWSWIRE
News & sentiment

ARS PHARMACEUTICALS (SPRY) — News & AI sentiment

ARS PHARMACEUTICALS (SPRY) news roundup. 8 stories aggregated over the last 30 days. Average 30-day sentiment is 46.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $284K — net selling of $284K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
8
avg sentiment 46.6/100
Insider net (90d)
$284K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on SPRY

Jul 17
Jul 17
Jul 15
Jul 7
Jul 7
ARS Pharmaceuticals appoints new CEO
Seeking Alpha50 · neutralgeneral
Jul 7
Jul 7
Jul 6
Jun 29
Jun 25
ARS Pharma: Strong Growth Meets A Coverage Wall
Seeking Alpha48 · neutralanalyst
Jun 25
Jun 25
Jun 25
Jun 24
Jun 4
ARS Pharma (SPRY) Q1 2026 Earnings Transcript
Yahoo Finance55 · neutralearnings
May 18
May 16
May 16
May 15
May 15
May 15
ARS Pharmaceuticals Q1 2026 Earnings Preview
Seeking Alpha34 · bearishearnings
May 14
Open SPRY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →